ALLKEM LIMITED (AKE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AKE - ALLKEM LIMITED

FNArena Sector : New Battery Elements
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: 0.36
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$11.62

25 Sep
2023

-0.390

OPEN

$11.71

-3.25%

HIGH

$11.85

3,223,755

LOW

$11.41

TARGET
$17.825 53.4% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
A11 . A4N . AGY . AVZ . BKT . BSX . CXO . DLI . EMN . GL1 . GLN . GT1 . INR . JRV . LKE . LLL . LPD . LPI . LTR . MNS . NMT . NVX . PLL . PLS . PSC . RNU . SRL . SYA . SYR . TLG . VUL .
FNARENA'S MARKET CONSENSUS FORECASTS
AKE: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx 103.0 106.4 xxx
DPS (cps) xxx 0.0 2.0 xxx
EPS Growth xxx 44.8% 3.3% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 10.9 xxx
Dividend Yield xxx N/A 0.2% xxx
Div Pay Ratio(%) xxx 0.0% 1.9% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx103.0
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx1,795.6 M
Book Value Per Share xxxxxxxxxxxxxxx802.1
Net Operating Cash Flow xxxxxxxxxxxxxxx1,175.8 M
Net Profit Margin xxxxxxxxxxxxxxx36.84 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx13.99 %
Return on Invested Capital xxxxxxxxxxxxxxx12.82 %
Return on Assets xxxxxxxxxxxxxxx9.21 %
Return on Equity xxxxxxxxxxxxxxx13.99 %
Return on Total Capital xxxxxxxxxxxxxxx22.21 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx441.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx84 M
Long Term Debt xxxxxxxxxxxxxxx408 M
Total Debt xxxxxxxxxxxxxxx492 M
Goodwill - Gross xxxxxxxxxxxxxxx781 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1,234 M
Price To Book Value xxxxxxxxxxxxxxx2.00

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx794.2 M
Capex % of Sales xxxxxxxxxxxxxxx44.23 %
Cost of Goods Sold xxxxxxxxxxxxxxx360 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx229 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx43 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

23/08/2023

1

Buy

$18.50

59.21%

Citi updates its modelling for Allkem to account for the FY23 result, which was ahead of expectations at the EBITDAX line, and FY24 guidance, which includes another six months delay at Sal de Vida.

Guidance for Olaroz is 22-26,000t of carbonate for stage I & 2, in line with expectations.

The broker retains a Buy rating given the re-rating the merger could bring, with the shareholder vote on track for this year and updates on Sal de Vida and James Bay to come with the scheme documentation. Target is reduced to $18.50 from $19.00.

FORECAST
Citi forecasts a full year FY24 dividend of 0.00 cents and EPS of 91.00 cents.
Citi forecasts a full year FY25 dividend of 0.00 cents and EPS of 105.60 cents.

UBS

xx/xx/xxxx

-1

xx xxxxxx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

-1

xx xxxxxx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >

AKE STOCK CHART

FNArena News on AKE

1
Allkem: On The Move

Sep 05 2023 - Technicals
2
Australian Broker Call *Extra* Edition – Aug 24, 2023

Aug 24 2023 - Daily Market Reports
3
FNArena Corporate Results Monitor – 23-08-2023

Aug 23 2023 - Australia
4
Australian Broker Call *Extra* Edition – Aug 02, 2023

Aug 02 2023 - Daily Market Reports
5
Rudi’s View: Awaiting The August Verdict

Aug 02 2023 - Rudi's View

Latest New Battery Elements News

1
ESG Focus: Grid Battery Innovation Barrelling Down

Sep 07 2023 - ESG Focus
2
Allkem: On The Move

Sep 05 2023 - Technicals
3
The Short Report – 24 Aug 2023

Aug 24 2023 - Weekly Reports
4
ESG Focus: Will Lithium Meet Its Waterloo?

Aug 10 2023 - ESG Focus
5
The Ups And Downs Of Mineral Resources

Jul 25 2023 - Australia
6
Syrah Resources: Near-Term Pain, Graphite Price Upside

Jul 20 2023 - Small Caps
7
Lithium Outlook Includes DLE Uncertainties

Jul 04 2023 - Commodities
8
Lithium: Longer Term Bullish

Jun 29 2023 - Technicals
9
Ignore Short Term Lithium Price Volatility

Jun 01 2023 - Commodities
10
Allkem: Breaking Out

May 09 2023 - Technicals